Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study (CROSBI ID 227673)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Fistonić, N ; Fistonić, I ; Lukanovič, A ; Findri Guštek, Š ; Sorta-Bilajac Turina, I ; Franić, D First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study // Climacteric, 18 (2015), supl 1; 37-42. doi: 10.3109/13697137.2015.1071126

Podaci o odgovornosti

Fistonić, N ; Fistonić, I ; Lukanovič, A ; Findri Guštek, Š ; Sorta-Bilajac Turina, I ; Franić, D

engleski

First assessment of short-term efficacy of Er:YAG laser treatment on stress urinary incontinence in women: prospective cohort study

Objectives This is the fi rst assessment of effi cacy and safety of the Er:YAG laser in the treatment of stress urinary incontinence. The aim of this study was to assess the short-term outcome of a non- invasive laser treatment for mild-to-severe stages of this condition and to check its applicability in different body mass index and age groups. Methods A prospective cohort, single-center study at the Ob/Gyn Clinic, Zagreb, Croatia recruited a consecutive sample of 73 female patients suffering from stress urinary incontinence. The procedure was performed with a 2940-nm Er:YAG laser (XS Dynamis, Fotona, Slovenia) designed to achieve heating up of vaginal mucosa to around 60 ° C, 500 – 700 μ m in depth. Results The score in the International Consultation on Incontinence Questionnaire- Urinary Incontinence Short Form was reduced to a median of 46% (95% confi dence interval 33 – 67% ; p  0.001). The reduction was signifi cantly higher in women with normal body mass index (67%) than in overweight women (25%), as well as in women younger than 39 years (100%) compared with those older than 60 years (8%) ( p  0.001). No serious adverse events were noticed. Conclusion This study of Er:YAG laser therapy in women has demonstrated a clinically relevant, short-term improvement of stress urinary incontinence, with minimal adverse events of a transient nature.

STRESS URINARY INCONTINENCE; ER: YAG LASER; QUALITY OF LIFE

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

18 (supl 1)

2015.

37-42

objavljeno

1369-7137

10.3109/13697137.2015.1071126

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita

Poveznice
Indeksiranost